Eli Lilly drug, Bamlanivimab and Etesevimab, approved for COVID care Featured Stories News State Eli Lilly drug, Bamlanivimab and Etesevimab, approved for COVID care Jacob Walton | Editor-in-Chief March 9, 2022 The Food and Drug Administration (FDA) issued an emergency use authorization for a combination of Bamlanivimab and... Read More Read more about Eli Lilly drug, Bamlanivimab and Etesevimab, approved for COVID care
